Gossamer Bio Inc at Bank of America Merrill Lynch Global Metals, Mining & Steel Conference Transcript
All right. Good afternoon, everyone. My name is Ying Huang, I'm the large cap biotech analyst here at BofA Merrill Lynch. We have our next presenting company, Gossamer Bio, which recently joined the rank of publicly traded companies. So congrats to both Bryan and Sheila here. So we do have Sheila Gujrathi, the CEO and founder of Gossamer Bio. We're also pleased to have -- well, we actually welcome Bryan back home, I guess I should say. Bryan Giraudo, the CFO, who used to be an employee here at Merrill Lynch.
With that, again, thank you for coming to Vegas and thank you for making the debut at BofA Health Care Conference here in Vegas. So I'm going to turn over the podium to maybe Sheila, who may have some bit of prepared remarks here, then we'll go into the fireside chat. Thank you, Sheila.
Thank you. Thank you, Ying. I will probably go through a few slides and then I'm happy to answer
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |